Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report

BACKGROUND: The use of isavuconazole is approved for the management of invasive aspergillosis and mucormycosis, only in adults, as no paediatric pharmacology studies have been reported to date. Very few paediatric cases have been published concerning the use of isavuconazole. Amphotericin B is the o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornu, Marjorie, Bruno, Bénédicte, Loridant, Séverine, Navarin, Pauline, François, Nadine, Lanternier, Fanny, Amzallag-Bellenger, Elisa, Dubos, François, Mazingue, Françoise, Sendid, Boualem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282241/
https://www.ncbi.nlm.nih.gov/pubmed/30522521
http://dx.doi.org/10.1186/s40360-018-0273-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282241/
https://www.ncbi.nlm.nih.gov/pubmed/30522521
http://dx.doi.org/10.1186/s40360-018-0273-7

Ejemplares similares